Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS

被引:173
作者
Williams, BG [1 ]
Dye, C [1 ]
机构
[1] WHO, Communicable Dis, CH-1211 Geneva 27, Switzerland
关键词
D O I
10.1126/science.1086845
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/ AIDS) has dramatically increased the incidence of tuberculosis (TB) in sub-Saharan Africa, where up to 60% of TB patients are coinfected with HIV and each year 200,000 TB deaths are attributable to HIV coinfection. Now HIV threatens control of TB in Asia, Eastern Europe, and Latin America. Antiretroviral ( ARV) drugs can prevent TB by preserving immunity, but cohort analysis shows that early therapy, plus high levels of coverage and compliance, will be needed to avert a significant fraction of TB cases. However, ARV drugs could enhance the treatment of TB, and TB programs provide an important entry point for the treatment of HIV/ AIDS.
引用
收藏
页码:1535 / 1537
页数:3
相关论文
共 34 条
[21]  
2-8
[22]   HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? [J].
Morgan, D ;
Mahe, C ;
Mayanja, B ;
Okongo, JM ;
Lubega, R ;
Whitworth, JAG .
AIDS, 2002, 16 (04) :597-603
[23]  
MSF, 2002, EQ ACC SCAL HIV AIDS
[24]  
Pilheu JA, 1997, INT J TUBERC LUNG D, V1, P422
[25]   Evolution of WHO policies for tuberculosis control, 1948-2001 [J].
Raviglione, MC ;
Pio, A .
LANCET, 2002, 359 (9308) :775-780
[26]  
Salamon R, 2002, J ACQ IMMUN DEF SYND, V29, P149, DOI 10.1097/00042560-200202010-00007
[27]   BIPHASIC RATE OF CD4+ CELL COUNT DECLINE DURING PROGRESSION TO AIDS CORRELATES WITH HIV-1 PHENOTYPE [J].
SCHELLEKENS, PTA ;
TERSMETTE, M ;
ROOS, MTL ;
KEET, RP ;
DEWOLF, F ;
COUTINHO, RA ;
MIEDEMA, F .
AIDS, 1992, 6 (07) :665-669
[28]  
Tan Darrell HS, 2003, BMC Int Health Hum Rights, V3, P2, DOI 10.1186/1472-698X-3-2
[29]  
*UNAIDS, 2003, UNAIDS0226E UNAIDS
[30]  
*WHO, 2003, WHOCDSTB2001287